Pimco Corporate is trading at 14.69 as of the 16th of February 2025; that is 0.2% down since the beginning of the trading day. The fund's open price was 14.72. Pimco Corporate has less than a 14 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 17th of January 2025 and ending today, the 16th of February 2025. Click here to learn more.
PIMCO Corporate Income Opportunity Fund is a closed-ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. It is co-managed by Pacific Investment Management Company LLC. The fund invests in fixed income markets across the globe. The company has 121.47 M outstanding shares of which 108.72 K shares are at this time shorted by investors with about 0.27 days to cover. More on Pimco Corporate Income
Pimco Corporate Income [PTY] is traded in USA and was established 16th of February 2025. Pimco Corporate is listed under FPA category by Fama And French industry classification. The fund is classified under FPA family. This fund at this time has 7.85 B in assets with no minimum investment requirementsPimco Corporate Income is currently generating return of 2.15% with the current yeild of 0.01%, while the total return for the last 3 years was 8.52%.
Pimco Corporate Income has about 5.69 M in cash with 308.11 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
Check Pimco Corporate Probability Of Bankruptcy
Pimco Corporate financial ratios help investors to determine whether Pimco Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pimco with respect to the benefits of owning Pimco Corporate security.
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance